Does the choice of thrombotic prophylactic drug depend on the known risk factors of patients with multiple myeloma in clinical practice?
Chalayer E et al.Thromb Res. 2016 May 7;143:101-102. doi: 10.1016/j.thromres.2016.05.003. [Epub ahead of print].
Impact of High-Cut-Off Dialysis on Renal Recovery in Dialysis-Dependent Multiple Myeloma Patients: Results from a Case-Control Study.
Gerth HU et al. PLoS One. 2016 May 6;11(5):e0154993. doi: 10.1371/journal.pone.0154993. eCollection 2016.